Erin N. Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erin N. Torres has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Armin Raznahan
Section on Developmental Neurogenomics, Human Genetics Branch, National Institute of Mental Health, Bethesda, MD, USA
3 shared publications - Liv S. Clasen
Section on Developmental Neurogenomics, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
2 shared publications - Lukas S. Schaffer
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, USA
2 shared publications - Siyuan Liu
Section on Developmental Neurogenomics, National Institute of Mental Health, Bethesda, MD, USA
2 shared publications - Tiffany Ajumobi
School of Medicine, The Johns Hopkins University, Baltimore, USA
2 shared publications - Ajay Nadig
Department of Biomedical Informatics, Harvard Medical School, Boston, USA
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by Springer Nature in Molecular Autism
Autism in Klinefelter Syndrome (47,XXY)
Background: Klinefelter Syndrome (KS;47,XXY) is associated with a range of neurodevelopmental and psychiatric outcomes, including higher autism rates. There is limited information regarding associations between autism diagnoses and clinical presentation profiles in KS: a gap with important implications for our understanding and care for autism and KS. Methods: We compared KS individuals with and without autism (KS-Aut;N=37, and KS-NoAut;N=53, respectively) aged 6–25 years for clinical outcomes including: multiple measures of autism-related symptoms; adaptive functioning; psychopathology; and executive functioning. Autism diagnostic status in KS was determined using ADI-R and ADOS-2 assessments in all KS individuals within a DSM-5 framework. Results: The autism diagnosis rate in KS was 41%(N=37/90). Autism symptoms were higher in the KS-Aut group than the KS-NoAut group, but with substantial overlap in symptom distributions between groups - especially for sensory differences. Moreover, autism symptoms were elevated for many within the KS-NoAut group. Comparison of autism symptomatology between the KS-Aut group and a non-syndromic sample of autistic individuals (ClinAut) highlighted fewer autistic symptoms in the KS-Aut group on nonverbal communication and repetitive behaviors/speech, but more sensory differences. The KS-NoAut group had significantly better adaptive functioning than the KS-Aut group, but both groups obtained lower scores relative to the normative sample. Psychopathology was significantly higher in the KS-Aut vs. KS-NoAut group for the CBCL Thought Problems scale. Executive functioning (EF) was impacted in both groups, with a relative sparing of EF behavioral regulation scales in the KS-NoAut group. Limitations: The KS cohort studies cannot be assumed to represent all KS individuals. Comparisons on the KS-Aut and ClinAut groups are preliminary given the lack of prospective matching for age and cognitive ability. Conclusions: Autism is highly prevalent in KS, though autistic differences may manifest differently relative to individuals with idiopathic autism. Many features show poor differentiation between autistic and non-autistic individuals with KS. Presence of autism in KS is associated with differences in adaptive functioning, psychopathology, and executive functioning. Thus, autism screening and evaluation in KS is extremely important to ensure appropriate access to necessary interventions.
- 22 September 2026
- Published by Springer Nature in Molecular Autism
Open AccessAutism in Klinefelter Syndrome (47,XXY)
Background: Klinefelter Syndrome (KS;47,XXY) is associated with a range of neurodevelopmental and psychiatric outcomes, including higher autism rates. There is limited information regarding associations between autism diagnoses and clinical presentation profiles in KS: a gap with important implications for our understanding and care for autism and KS. Methods: We compared KS individuals with and without autism (KS-Aut;N=37, and KS-NoAut;N=53, respectively) aged 6–25 years for clinical outcomes including: multiple measures of autism-related symptoms; adaptive functioning; psychopathology; and executive functioning. Autism diagnostic status in KS was determined using ADI-R and ADOS-2 assessments in all KS individuals within a DSM-5 framework. Results: The autism diagnosis rate in KS was 41%(N=37/90). Autism symptoms were higher in the KS-Aut group than the KS-NoAut group, but with substantial overlap in symptom distributions between groups - especially for sensory differences. Moreover, autism symptoms were elevated for many within the KS-NoAut group. Comparison of autism symptomatology between the KS-Aut group and a non-syndromic sample of autistic individuals (ClinAut) highlighted fewer autistic symptoms in the KS-Aut group on nonverbal communication and repetitive behaviors/speech, but more sensory differences. The KS-NoAut group had significantly better adaptive functioning than the KS-Aut group, but both groups obtained lower scores relative to the normative sample. Psychopathology was significantly higher in the KS-Aut vs. KS-NoAut group for the CBCL Thought Problems scale. Executive functioning (EF) was impacted in both groups, with a relative sparing of EF behavioral regulation scales in the KS-NoAut group. Limitations: The KS cohort studies cannot be assumed to represent all KS individuals. Comparisons on the KS-Aut and ClinAut groups are preliminary given the lack of prospective matching for age and cognitive ability. Conclusions: Autism is highly prevalent in KS, though autistic differences may manifest differently relative to individuals with idiopathic autism. Many features show poor differentiation between autistic and non-autistic individuals with KS. Presence of autism in KS is associated with differences in adaptive functioning, psychopathology, and executive functioning. Thus, autism screening and evaluation in KS is extremely important to ensure appropriate access to necessary interventions.
- Open Access
Novel tools for comparing the architecture of psychopathology between neurogenetic disorders: An application to X- vs. Y-chromosome aneuploidy effects in males
Background: Psychiatric symptoms are typically highly inter-correlated at the group level. Collectively, these correlations define the architecture of psychopathology—informing taxonomic and mechanistic models in psychiatry. However, to date, it remains unclear if this architecture differs between etiologically distinct subgroups, despite the core relevance of this understanding for personalized medicine. Here, we introduce a new analytic pipeline to probe group differences in the psychopathology architecture—demonstrated through comparison of two distinct neurogenetic disorders. Methods: We use a large questionnaire battery in 300 individuals aged 5-25 years ( n = 102 XXY/KS, n = 64 XYY, n = 134 age-matched XY) to characterize the structure of correlations among 53 diverse measures of psychopathology in XXY/KS and XYY syndrome—enabling us to compare the effects of X- vs. Y-chromosome dosage on the architecture of psychopathology at multiple, distinctly informative levels. Results: Behavior correlation matrices describe the architecture of psychopathology in each syndrome. Comparison of matrix row averages reveals that autism-related features and externalizing symptoms are most differentially coupled to other aspects of psychopathology in XXY/KS vs. XYY. Clustering the difference between matrices captures coordinated group differences in pairwise coupling between measures of psychopathology: XXY/KS increases coherence among externalizing, internalizing, and autism-related features, while XYY syndrome shows greater coherence in dissociality and early neurodevelopmental impairment. Conclusions: These methods offer new insights into X- and Y-chromosome dosage effects on behavior, and our shared code can now be applied to other clinical groups of interest—helping to hone mechanistic models and inform the tailoring of care.
Open AccessNovel tools for comparing the architecture of psychopathology between neurogenetic disorders: An application to X- vs. Y-chromosome aneuploidy effects in males
Background: Psychiatric symptoms are typically highly inter-correlated at the group level. Collectively, these correlations define the architecture of psychopathology—informing taxonomic and mechanistic models in psychiatry. However, to date, it remains unclear if this architecture differs between etiologically distinct subgroups, despite the core relevance of this understanding for personalized medicine. Here, we introduce a new analytic pipeline to probe group differences in the psychopathology architecture—demonstrated through comparison of two distinct neurogenetic disorders. Methods: We use a large questionnaire battery in 300 individuals aged 5-25 years ( n = 102 XXY/KS, n = 64 XYY, n = 134 age-matched XY) to characterize the structure of correlations among 53 diverse measures of psychopathology in XXY/KS and XYY syndrome—enabling us to compare the effects of X- vs. Y-chromosome dosage on the architecture of psychopathology at multiple, distinctly informative levels. Results: Behavior correlation matrices describe the architecture of psychopathology in each syndrome. Comparison of matrix row averages reveals that autism-related features and externalizing symptoms are most differentially coupled to other aspects of psychopathology in XXY/KS vs. XYY. Clustering the difference between matrices captures coordinated group differences in pairwise coupling between measures of psychopathology: XXY/KS increases coherence among externalizing, internalizing, and autism-related features, while XYY syndrome shows greater coherence in dissociality and early neurodevelopmental impairment. Conclusions: These methods offer new insights into X- and Y-chromosome dosage effects on behavior, and our shared code can now be applied to other clinical groups of interest—helping to hone mechanistic models and inform the tailoring of care.
- 1 September 2021
- Published by Wolters Kluwer Health in AJN, American Journal of Nursing
- Vol. 121 (9) , 11
The Need for Greater Awareness of Sex Chromosome Variations
Health care providers remain ill prepared to recognize these conditions and support patients and their families.
- 1 September 2021
- Published by Wolters Kluwer Health in AJN, American Journal of Nursing
- Vol. 121 (9) , 11
The Need for Greater Awareness of Sex Chromosome Variations
Health care providers remain ill prepared to recognize these conditions and support patients and their families.
- Open Access
Effects of Human Sex Chromosome Dosage on Spatial Chromosome Organization
Sex chromosome aneuploidies (SCAs) are common genetic syndromes characterized by the presence of an aberrant number of X and Y chromosomes due to meiotic defects. These conditions impact structure and function of diverse tissues, but the proximal effects of SCA on genome organization are unknown. Here, to determine the consequences of SCAs on global genome organization, we have analyzed multiple architectural features of chromosome organization in a comprehensive set of primary cells from SCA patients with various ratios of X and Y chromosomes by use of imaging-based high-throughput Chromosome Territory Mapping (HiCTMap). We find that X chromosome supernumeracy does not affect the size, volume or nuclear position of the Y chromosome or an autosomal chromosome. In contrast, the active X chromosome undergoes architectural changes as a function of increasing X copy number, as measured by a decrease in size and an increase in circularity, which is indicative of chromatin compaction. With Y chromosome supernumeracy, Y chromosome size is reduced suggesting higher chromatin condensation. The radial positioning of chromosomes is unaffected in SCA karyotypes. Taken together, these observations document changes in genome architecture in response to alterations in sex chromosome numbers and point to trans-effects of dosage compensation on chromosome organization.
Open AccessEffects of Human Sex Chromosome Dosage on Spatial Chromosome Organization
Sex chromosome aneuploidies (SCAs) are common genetic syndromes characterized by the presence of an aberrant number of X and Y chromosomes due to meiotic defects. These conditions impact structure and function of diverse tissues, but the proximal effects of SCA on genome organization are unknown. Here, to determine the consequences of SCAs on global genome organization, we have analyzed multiple architectural features of chromosome organization in a comprehensive set of primary cells from SCA patients with various ratios of X and Y chromosomes by use of imaging-based high-throughput Chromosome Territory Mapping (HiCTMap). We find that X chromosome supernumeracy does not affect the size, volume or nuclear position of the Y chromosome or an autosomal chromosome. In contrast, the active X chromosome undergoes architectural changes as a function of increasing X copy number, as measured by a decrease in size and an increase in circularity, which is indicative of chromatin compaction. With Y chromosome supernumeracy, Y chromosome size is reduced suggesting higher chromatin condensation. The radial positioning of chromosomes is unaffected in SCA karyotypes. Taken together, these observations document changes in genome architecture in response to alterations in sex chromosome numbers and point to trans-effects of dosage compensation on chromosome organization.